title: Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.
abstract: Familial combined hyperlipidemia (FCH) is a common genetic lipid disorder with a frequency of 1-2% in the population. In addition to the hypercholesterolemia and/or hypertriglyceridemia that affected individuals exhibit, small, dense LDL particles and decreased HDL-cholesterol levels are traits frequently associated with FCH. Recently, we reported that families with FCH and families enriched for coronary artery disease (CAD) share genetic determinants for the atherogenic lipoprotein phenotype (ALP), a profile presenting with small, dense LDL particles, decreased HDL-cholesterol levels, and increased triglyceride levels. Other studies in normolipidemic populations have shown that the hepatic lipase (HL) gene is linked to HDL-cholesterol levels and that a polymorphism within the HL promoter (-514C-->T) is associated with increased HDL-cholesterol levels as well as larger, more buoyant LDL particles. In the present study, we tested whether the HL gene locus also contributes to ALP in a series of Dutch FCH families using nonparametric sibpair linkage analysis and association analysis. Evidence for linkage of LDL particle size (P < 0.019), HDL-cholesterol (P < 0.003), and triglyceride levels (P < 0.026) to the HL gene locus was observed. A genome scan in a subset of these families exhibited evidence for linkage of PPD (LOD = 2.2) and HDL-cholesterol levels (LOD = 1.2) to the HL gene locus as well. The -514C-->T promoter polymorphism was significantly associated (P < 0.0001) with higher HDL-cholesterol levels in the unrelated males of this population, but not in unrelated females. No association was observed between the polymorphism and LDL particle size or triglyceride levels. Our results provide support that ALP is a multigenic trait and suggest that the relationship between small, dense LDL particles, HDL-cholesterol, and triglyceride levels in FCH families is due, in part, to common genetic factors.
authors.affiliation: Department of Microbiology, University of California, Los Angeles, CA 90095, USA.
authors.forename: H
authors.initials: H
authors.lastname: Allayee
authors.forename: K M
authors.initials: KM
authors.lastname: Dominguez
authors.forename: B E
authors.initials: BE
authors.lastname: Aouizerat
authors.forename: R M
authors.initials: RM
authors.lastname: Krauss
authors.forename: J I
authors.initials: JI
authors.lastname: Rotter
authors.forename: J
authors.initials: J
authors.lastname: Lu
authors.forename: R M
authors.initials: RM
authors.lastname: Cantor
authors.forename: T W
authors.initials: TW
authors.lastname: de Bruin
authors.forename: A J
authors.initials: AJ
authors.lastname: Lusis
mesh_terms: D000328:Adult; D008076:Cholesterol, HDL / Q000097:blood; D003324:Coronary Artery Disease / Q000097:blood / Q000201:enzymology / Q000235:genetics; D005260:Female; D008040:Genetic Linkage; D006801:Humans; D006950:Hyperlipidemia, Familial Combined / Q000097:blood / Q000201:enzymology* / Q000235:genetics*; D008049:Lipase / Q000235:genetics*; D008074:Lipoproteins / Q000097:blood*; D008099:Liver / Q000201:enzymology*; D008297:Male; D008875:Middle Aged; D010641:Phenotype
chemical_list: D008076:Cholesterol, HDL; D008074:Lipoproteins; D008049:Lipase